• Tetracycline in Research: Protocols, Applications & Troubles

  2026-04-24

  Tetracycline stands out as a broad-spectrum polyketide antibiotic not only for its classical role in selection and inhibition of bacterial protein synthesis but also for its expanding use in advanced ribosomal and ER stress research. This article delivers a practical, evidence-driven guide to maximizing tetracycline’s value in experimental workflows, integrating troubleshooting insights and highlighting key innovations from recent disease modeling studies.

• HyperScribe™ Poly (A) Tailing Kit: Optimizing mRNA Stability

  2026-04-24

  The HyperScribe™ Poly (A) Tailing Kit empowers researchers to produce highly stable, transfection-ready mRNA by enzymatically polyadenylating in vitro transcripts with E. coli Poly (A) Polymerase. Its robust, reproducible protocol accelerates advanced gene expression workflows and overcomes common RNA processing bottlenecks.

• Praeruptorin A: Translational Leverage in Cancer and Inflamm

  2026-04-23

  This expert thought-leadership article explores Praeruptorin A, an angular pyranocoumarin compound, as a multifaceted research tool for translational scientists. By dissecting its mechanistic roles in ferroptosis inhibition, anti-inflammatory signaling, and metastatic suppression—especially in hepatocellular carcinoma—this piece provides actionable guidance, protocol insights, and a visionary outlook for advancing disease-modifying research. Drawing on primary and secondary literature as well as workflow best practices, it goes beyond standard product summaries to map strategic applications for Praeruptorin A in experimental and preclinical models.

• Structural Insights into HCAR3 Agonist Binding and Selectivi

  2026-04-23

  Ye et al. (2025) provide high-resolution cryo-EM structures of the hydroxycarboxylic acid receptor HCAR3 bound to selective agonists, including (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid (Acifran). Their findings elucidate the molecular determinants of ligand recognition and selectivity, paving the way for rational design of specific hypolipidemic agents with improved safety profiles.

• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio

  2026-04-22

  The reference study identifies ATG9A and PTOV1 as new 14-3-3 binding proteins, elucidating their roles in autophagy and cancer signaling. These findings significantly expand our molecular understanding of tumorigenic mechanisms and highlight new potential targets for regulated cell therapy and conditional gene expression research.

• DAPI (hydrochloride): Optimizing DNA Visualization in Tumor

  2026-04-22

  DAPI (hydrochloride) delivers high-contrast, sequence-selective DNA staining, accelerating cell cycle analysis and tumor microenvironment profiling. This guide walks through advanced workflows, robust troubleshooting, and expert tips—empowering precise research outcomes with APExBIO's trusted staining reagent.

• APEX2 Is Essential for TERT Expression in Human Stem Cells

  2026-04-21

  This study demonstrates that the DNA repair enzyme APEX2, unlike its paralog APEX1, is required for efficient telomerase reverse transcriptase (TERT) gene expression in human embryonic stem cells and melanoma cells. The findings reveal novel mechanistic links between DNA repair, repetitive DNA elements, and the regulation of telomerase, with implications for stem cell biology, aging, and cancer.

• OTC-Mediated Ornithine Regulation Drives Realgar CNS Toxicit

  2026-04-21

  This study delineates how realgar, an arsenic-containing compound, disrupts the liver–brain axis by inhibiting hepatic ornithine transcarbamylase (OTC), leading to ornithine accumulation and subsequent repression of astrocytic glycolysis via ZBTB7A. These findings clarify the molecular cascade underlying realgar-induced CNS toxicity and highlight new directions for targeted prevention and mechanistic research.

• (S)-(+)-Dimethindene maleate: Technical Guidance for M2 Anta

  2026-04-20

  (S)-(+)-Dimethindene maleate enables precise, receptor-selective pharmacological interrogation in autonomic regulation, cardiovascular, and respiratory research. It is not suitable for diagnostic, clinical, or long-term solution-based applications. Use is restricted to bench workflows that require high-purity, well-characterized M2 muscarinic receptor antagonists.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-04-20

  This study reveals that HOXC8 functions as a transcriptional repressor of caspase-1, thereby preventing pyroptotic cell death in non-small cell lung carcinoma (NSCLC). The findings highlight a novel epigenetic mechanism by which HOXC8 and HDAC1/2 interaction controls inflammasome-mediated cell fate, with potential implications for targeting tumor immunity and cell death pathways.

• Ziprasidone Augmentation in Escitalopram-Treated Anxious Dep

  2026-04-19

  The referenced study rigorously evaluated ziprasidone augmentation in patients with major depressive disorder (MDD) and comorbid anxiety who had incomplete response to escitalopram. Findings suggest that ziprasidone provided equal antidepressant efficacy in both anxious and nonanxious subgroups, but clinically meaningful anxiolytic benefit was not observed. These results inform the nuanced understanding of SSRI augmentation strategies in complex depression profiles.

• Halazone: Applied Workflows for Antimicrobial Sulfonamide De

  2026-04-18

  Halazone stands out as a dual-action antimicrobial sulfonamide derivative, uniquely bridging high-precision water disinfection and neuronal sodium channel research. This article delivers actionable protocols, troubleshooting strategies, and advanced application insights, empowering researchers to maximize performance in microbiology and neurophysiology with APExBIO’s Halazone.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-04-17

  This study uncovers how MAPK10 phosphorylation of keratin 16 triggers its ubiquitination and degradation, thereby restraining non-small cell lung cancer (NSCLC) metastasis. The findings illuminate a new regulatory axis with prognostic and therapeutic potential in NSCLC progression.

• Strategic Inhibition of NF-κB: BMS-345541 in Translational R

  2026-04-16

  This article examines the mechanistic and strategic landscape of BMS-345541 (free base) as a selective IKK-1/IKK-2 inhibitor, highlighting its pivotal role in modulating NF-κB signaling for inflammation and cancer research. Drawing on recent findings and best practices, it provides actionable guidance for translational researchers aiming to harness precise NF-κB pathway inhibition in preclinical models.

• Dibutyryl-cAMP, Sodium Salt: Precision Tools for Neuronal Co

  2026-04-15

  Discover how Dibutyryl-cAMP, sodium salt enables highly controlled cAMP signaling pathway research and advances the efficiency of fibroblast-to-neuron conversion. This deep-dive explores unique mechanistic insights and practical assay optimizations for experimental neuroscience.

444 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page